An interesting feature by Vox (from the perspective of the US, which would appear to have all the jabs) on why you should never judge a vaccine by its stated efficacy rate.
I find it a bit odd that most of these companies had their jabs developed and released around the same time. Almost as if they already had them developed, but couldn’t get them approved for release for some reason? But what do I know? I’m sure I can just blindly trust the same industry and regulators that brought us oxycontin.
wearnicehats
It’s very interesting and, if factually correct, it shows why using case numbers as indicative of the extent of the problem is seriously flawed.
I find it a bit odd that most of these companies had their jabs developed and released around the same time. Almost as if they already had them developed, but couldn’t get them approved for release for some reason? But what do I know? I’m sure I can just blindly trust the same industry and regulators that brought us oxycontin.
It’s very interesting and, if factually correct, it shows why using case numbers as indicative of the extent of the problem is seriously flawed.